Cargando…
The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
Objective: Methamphetamine and cannabis are two widely used substances among people living with HIV (PLWH). Whereas methamphetamine use has been found to worsen HIV-associated neurocognitive impairment, the effects of combined cannabis and methamphetamine use disorder on neurocognition in PLWH are n...
Autores principales: | Rogers, Jeffrey M., Iudicello, Jennifer E., Marcondes, Maria Cecilia G., Morgan, Erin E., Cherner, Mariana, Ellis, Ronald J., Letendre, Scott L., Heaton, Robert K., Grant, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058939/ https://www.ncbi.nlm.nih.gov/pubmed/36992383 http://dx.doi.org/10.3390/v15030674 |
Ejemplares similares
-
Reply to Augello, P.A.; Wu, J. Comment on “Rogers et al. The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition. Viruses 2023, 15, 674”
por: Rogers, Jeffrey M., et al.
Publicado: (2023) -
Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV
por: Saloner, Rowan, et al.
Publicado: (2022) -
Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood
por: Ellis, Ronald J., et al.
Publicado: (2020) -
Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning
por: Bharti, Ajay R, et al.
Publicado: (2016) -
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder
por: Saloner, Rowan, et al.
Publicado: (2022)